Genmab — November 2018
-
DaraPomD in AL amyloidosis -abstract
https://journals.sagepub.com/doi/full/10.1177/1078155218815305 -
-
Er der nogle der ved om der er søgt RTOR?
-
Obs. Zealand Pharma Q&A starter kl. 15.
-
small new trial Ixazomib -Daratumumab Without Dexamethasone (IDara) in Elderly Relapse Refractory Multiple Myeloma (IDARA) https://clinicaltrials.gov/ct2/show/NCT03757221?term=NCT03757221&rank=1
-
Servicemeddelelse: Transcript fra Q&A med Zealand Pharma.
http://www.proinvestor.com/ir/q-and-a/dk -
Apropos mine betragtninger i går omkring markedsstemningen og Genmabs kurs: https://borsen.dk/nyheder/avisen/artikel/11/212984/artikel.html?hl=YToxOntpOjA7czo0OiJNYWRzIjt9&fbclid=IwAR2IhW1GP8TC-dxZPnA0193PHGL9SgsAl_GcGpmrAJm1fLKFycFCDSgf_iQ
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind